Molecule AG

Molecule AG is a decentralized biotech company based in Berlin, Germany, established in 2019 by Paul Kohlhaas. The company focuses on accelerating innovation in the pharmaceutical industry through a web3 marketplace for research-related intellectual property (IP). Molecule connects scientists, patients, academics, and biotech companies to enhance drug development using a collaborative market model. The company’s platform features a decentralized protocol that allows IP creators to share ownership of their innovations in exchange for liquidity and research funding. Molecule supports the creation of biotech decentralized autonomous organizations (DAOs), enabling communities to govern and own research-related IP. Key offerings include a marketplace for biotech IP using tokenized assets called IP-NFTs, a hybrid token-and-equity framework, and open-source developer tools. Molecule has raised approximately $13 million in funding to support its mission of democratizing drug discovery and development.